External Quality Assessment for the Detection of Chlamydia trachomatis in Urine Using Molecular Techniques in Belgium
Table 3
Method used per year and per participant.
Methods
2008a
2008b
2009
2010
2011a
2011b
2012
Real time PCR
Abbott real time CT1
1
2
2
2
2
2
2
Abbott real time CT/NG1
1
2
8
10
13
15
Nanogen Chlamydia tr. Q-PCR Alert kit2
1
1
1
1
1
1
Shangai bio-tech IMtec CT real time PCR kit3
1
Roche Cobas TaqMan CT4
4
4
9
Roche Cobas TaqMan CT v2.0 Roche4
14
14
12
12
Roche Cobas TaqMan CT/NG4
1
3
7
Qiagen artus C. trachomatis PCR kit5
5
5
7
5
5
5
4
Diagenode DIA-CT-0506
1
1
2
1
Real time in house
1
3
5
3
4
4
Gen-Probe Aptima combo 2 Assay7
1
Gen-Probe PACE CT7
1
Gen-Probe PACE 2 CT7
SDA
Becton Dickinson ProbeTec ET8
11
10
9
7
6
6
5
PCR-ELISA
Roche Amplicor CT4
1
Roche Amplicor CT/NG4
12
11
8
4
2
3
Roche Cobas Amplicor CT/NG4
10
10
17
3
4
1
1
Other
Nasba in house
2
Hain Lifescience Genoquick CT9
1
Total of the participants
47
50
48
54
50
51
55
Abbott laboratories, Abbott Park, IL, USA. 2Nanogen Advanced Diagnostics, Trezzano sul Naviglio, Italy. 3IMTEC, Berlin, Germany. 4Roche Molecular diagnostics, Pleasanton, USA. 5Qiagen, Venlo, Netherlands. 6Diagenode, Liège, Belgium. 7Gen-Probe Incorporated, San Diego, USA. 8Becton Dickinson and Co, Sparks, USA. 9Hain Lifesceince GmBH, Nehren, Germany.